These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33239649)

  • 1. Longitudinal analysis of premotor anthropometric and serological markers of Parkinson's disease.
    Yokoi K; Hattori M; Satake Y; Tanaka Y; Sato M; Hashizume A; Hori A; Kawashima M; Hirakawa A; Watanabe H; Katsuno M
    Sci Rep; 2020 Nov; 10(1):20524. PubMed ID: 33239649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study).
    Pont-Sunyer C; Hotter A; Gaig C; Seppi K; Compta Y; Katzenschlager R; Mas N; Hofeneder D; Brücke T; Bayés A; Wenzel K; Infante J; Zach H; Pirker W; Posada IJ; Álvarez R; Ispierto L; De Fàbregues O; Callén A; Palasí A; Aguilar M; Martí MJ; Valldeoriola F; Salamero M; Poewe W; Tolosa E
    Mov Disord; 2015 Feb; 30(2):229-37. PubMed ID: 25449044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study.
    Liepelt-Scarfone I; Gauss K; Maetzler W; Müller K; Bormann C; Fruhmann Berger M; Timmers M; Streffer J; Berg D
    Neuroepidemiology; 2013; 41(3-4):174-82. PubMed ID: 24051361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premotor symptoms and the risk of Parkinson's disease: A case-control study in Mexican population.
    Rodríguez-Violante M; de Saráchaga AJ; Cervantes-Arriaga A; Davila-Avila NM; Carreón-Bautista E; Estrada-Bellmann I; Parra-López G; Cruz-Fino D; Pascasio-Astudillo F
    Clin Neurol Neurosurg; 2017 Sep; 160():46-49. PubMed ID: 28644969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of RNA Blood Biomarkers in Individuals at Risk of Parkinson's Disease.
    Santiago JA; Potashkin JA
    J Parkinsons Dis; 2017; 7(4):653-660. PubMed ID: 28922168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of premotor symptoms in patients with newly diagnosed PD: a nationwide, population-based, case-control study in Taiwan.
    Wu YH; Liao YC; Chen YH; Chang MH; Lin CH
    PLoS One; 2015; 10(6):e0130282. PubMed ID: 26107935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.
    Herz DM; Siebner HR; Hulme OJ; Florin E; Christensen MS; Timmermann L
    Neuroimage; 2014 Apr; 90():15-23. PubMed ID: 24269570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
    Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
    Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa).
    Mollenhauer B; Zimmermann J; Sixel-Döring F; Focke NK; Wicke T; Ebentheuer J; Schaumburg M; Lang E; Friede T; Trenkwalder C;
    Mov Disord; 2019 Jan; 34(1):67-77. PubMed ID: 30468694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic drugs restore facilitatory premotor-motor interactions in Parkinson disease.
    Mir P; Matsunaga K; Gilio F; Quinn NP; Siebner HR; Rothwell JC
    Neurology; 2005 Jun; 64(11):1906-12. PubMed ID: 15955942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyposmia correlates with SNCA variant and non-motor symptoms in Chinese patients with Parkinson's disease.
    Chen W; Kang WY; Chen S; Wang Y; Xiao Q; Wang G; Liu J; Chen SD
    Parkinsonism Relat Disord; 2015 Jun; 21(6):610-4. PubMed ID: 25921825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of lipid levels with motor and cognitive function and decline in advanced Parkinson's disease in the Mark-PD study.
    Choe CU; Petersen E; Lezius S; Cheng B; Schulz R; Buhmann C; Pötter-Nerger M; Daum G; Blankenberg S; Gerloff C; Schwedhelm E; Zeller T
    Parkinsonism Relat Disord; 2021 Apr; 85():5-10. PubMed ID: 33636481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects.
    Kim JS; Park IS; Park HE; Kim SY; Yun JA; Jung CK; Sung HY; Lee JK; Kang WK
    Neurol Sci; 2017 Jan; 38(1):171-179. PubMed ID: 27803984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lipid levels with motor and cognitive function and decline in Parkinson's disease.
    Gu L; Shu H; Wang Y; Li H; Wang P
    Psychogeriatrics; 2024 Jul; 24(4):802-810. PubMed ID: 38567766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease.
    Li J; Gu C; Zhu M; Li D; Chen L; Zhu X
    Psychogeriatrics; 2020 Mar; 20(2):180-188. PubMed ID: 31828903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications.
    Chen H; Burton EA; Ross GW; Huang X; Savica R; Abbott RD; Ascherio A; Caviness JN; Gao X; Gray KA; Hong JS; Kamel F; Jennings D; Kirshner A; Lawler C; Liu R; Miller GW; Nussbaum R; Peddada SD; Rick AC; Ritz B; Siderowf AD; Tanner CM; Tröster AI; Zhang J
    Environ Health Perspect; 2013; 121(11-12):1245-52. PubMed ID: 23933572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premotor Parkinson's disease: Overview of clinical symptoms and current diagnostic methods.
    Kaiserova M; Grambalova Z; Kurcova S; Otruba P; Prikrylova Vranova H; Mensikova K; Kanovsky P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Jun; 165(2):103-112. PubMed ID: 33542542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients.
    Swanson CR; Berlyand Y; Xie SX; Alcalay RN; Chahine LM; Chen-Plotkin AS
    Mov Disord; 2015 Oct; 30(12):1648-56. PubMed ID: 26207725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood inflammatory markers in early Parkinson's disease.
    Kim R; Kim HJ; Kim A; Jang M; Kim A; Kim Y; Yoo D; Im JH; Choi JH; Jeon B
    J Clin Neurosci; 2018 Dec; 58():30-33. PubMed ID: 30454693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.